AlphaStocks

MRNA vs VAL

As of Sep 20, 2026, Moderna (MRNA) scores 5.3/10 and Valaris (VAL) 4.6/10 on AlphaStocks' five-model composite, so MRNA scores higher.

MRNA

Moderna, Inc.

5.3

Consider Buy

$153.99

VAL

Valaris Ltd

4.6

Weak

$83.77

MRNA vs VAL: Which is the Better Investment?

Moderna, Inc. (MRNA) scores 5.3/10 while Valaris Ltd (VAL) scores 4.6/10 on AlphaStocks' composite model. Moderna, Inc. has the higher composite rating of Consider Buy.

This comparison is algorithmically generated and is not financial advice.

MetricMRNAVAL
Scores & Fundamentals
Composite Score5.3/104.6/10
RatingConsider BuyWeak
Price$153.99$83.77
P/E Ratio6.0
ROE-31.4%35.0%
Market Cap$61B$6B
Fair Value
Dividend Yield
Sector Rank#93 of 168#37 of 80
Model Verdicts
PiotroskiNeutralStrong
BuffettCautionAttractive
GrahamNeutralNeutral
LynchLimited DataNeutral
GreenblattCautionAttractive
View full MRNAanalysis →View full VALanalysis →

Related comparisons

Compare any two stocks →

MRNA vs VAL: Which Stock Scores Higher?

Moderna, Inc. (MRNA) is in the Health Care sector; Valaris Ltd (VAL) is in Energy. MRNA currently leads with a composite score of 5.3/10 (Consider Buy) compared to VAL's 4.6/10 (Weak).

The AlphaStocks composite score evaluates each stock across four dimensions: Quality (business strength measured by Piotroski F-Score and Buffett quality criteria), Value (discount to intrinsic worth using Graham, Lynch, and Greenblatt models), Momentum (6-month price trend), and Timing (a confirmation signal that requires both value and momentum to align). A higher composite score indicates stronger overall fundamentals combined with favorable market conditions.

This comparison uses the same scoring framework for both companies, ensuring an apples-to-apples evaluation. Scores are recalculated daily after market close using data from SEC filings and market prices. Read the full methodology to understand how each model contributes to the composite score.

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer